Seattle Neuropsychiatric Treatment Center — Bellevue, Washington

Seattle Neuropsychiatric Treatment Center is a clinical research site located in Bellevue, Washington, United States 98004.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Seattle Neuropsychiatric Treatment Center has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Depressive Disorder, Major, Treatment Resistant Depression, PostTraumatic Stress Disorder.

Sponsors: Usona Institute, atai Therapeutics, Inc., LivaNova.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bellevue

Browse all research sites in Washington · View every site in Bellevue

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seattle Neuropsychiatric Treatment Center?

Seattle Neuropsychiatric Treatment Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seattle Neuropsychiatric Treatment Center conducted?

Seattle Neuropsychiatric Treatment Center has 5 clinical trials on record, with 3 currently active. Their work covers Depressive Disorder, Major, Treatment Resistant Depression, PostTraumatic Stress Disorder.

Is Seattle Neuropsychiatric Treatment Center accredited by Crixeo Clinical Trials?

Seattle Neuropsychiatric Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seattle Neuropsychiatric Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.